Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study

PLoS One. 2024 Mar 19;19(3):e0298271. doi: 10.1371/journal.pone.0298271. eCollection 2024.

Abstract

Multiple Sclerosis (MS) is an immune-related disease and the relationship between MS and cancer has raised attention. Previous studies of the relationship between MS and cancer have reached conflicting conclusions. In this study, the two-sample MR method is used to investigate whether MS has a causal correlation with cancers and offer scientific evidence for cancer prevention. Single nucleotide polymorphisms (SNPs) related to MS were obtained from the genome-wide association study (GWAS) based on International Multiple Sclerosis Genetics Consortium (IMSGC) and SNPs related to 15 types of cancers were obtained from the GWASs based on UK Biobank. Inverse variance weighted (IVW) method was mainly used to assess causal effects. Sensitivity analyses were conducted with Cochran's Q-test, MR Egger intercept, leave-one-out test, and MR Steiger method. IVW analysis showed that MS was only associated with a marginal increased risk of cervical cancer (OR 1.0004, 95% CI 1.0002-1.0007, p = 0.0003). Sensitivity analyses showed that the results of MR analysis were robust and found no heterogeneity, no pleiotropy, and no reverse causation. In conclusion, this study finds no causal relationship between MS and 15 types of cancers except cervical cancer.

MeSH terms

  • Female
  • Genome-Wide Association Study
  • Humans
  • Mendelian Randomization Analysis
  • Multiple Sclerosis* / epidemiology
  • Multiple Sclerosis* / genetics
  • Nonoxynol
  • Uterine Cervical Neoplasms*

Substances

  • Nonoxynol

Grants and funding

This study was supported by the Guangzhou Municipal Science and Technology Bureau (202206080012 to B.Z.) and China postdoctoral science foundation (2022M723682 to T.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.